Tred Avon Family Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
47,994
-7,975
-14% -$209K 0.35% 75
2026
Q1
$1.57M Buy
55,969
+5,402
+11% +$144K 0.52% 45
2025
Q4
$1.26M Sell
50,567
-5,167
-9% -$130K 0.41% 61
2025
Q3
$1.42M Buy
+55,734
New +$1.38M 0.49% 49

Other funds holding PFE

Tred Avon Family Wealth's PFE Position: Q2 2026 in Review

Tred Avon Family Wealth reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $209K and leaving 47,994 shares worth $1.16M. The position accounts for 0.35% of the portfolio, ranked #75.

Tred Avon Family Wealth first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.57M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tred Avon Family Wealth held 47,994 shares of Pfizer worth $1.16M as of Q2 2026.
  • Tred Avon Family Wealth sold 7,975 Pfizer shares in Q2 2026, an estimated $209K.
  • Pfizer made up 0.35% of Tred Avon Family Wealth's portfolio in Q2 2026, its #75 holding.
  • Tred Avon Family Wealth first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Tred Avon Family Wealth's Pfizer position peaked at $1.57M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.